Horus Pharma SAS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Horus Pharma SAS - overview
Established
2003
Location
-, -, France
Primary Industry
Pharmaceuticals
About
Based in Saint-Laurent du Var, France, and founded in 2003 by CEO Claude Claret, Martine Claret, Horus Pharma SAS is a pharmaceutical company that specializes in ophthalmology, micronutrition, dermatology, contactology, and surgery products. In March 2022, Eurazeo invested EUR 23 million in Horus Pharma SAS. Horus Pharma provides ophthalmology products for allergy, cataracts, healing, glaucoma, infection, soreness, and more. The company also offers food supplements, such as eye micronutrition; dermatology products like blepharitis, and meibomian gland dysfunction; and contactology products like rigid lenses care, and soft contact lenses care.
In addition, Horus Pharma performs cornea, lens, and retina surgeries. The company plans to use its proceeds from March 2022 investment to accelerate its international expansion, expand research and development activities, and develop the next generation of management.
Current Investors
Eurazeo
Primary Industry
Pharmaceuticals
Sub Industries
Optometrists & Opticians Products and Services, Dermatology, Pharmaceutical Research & Development
Website
www.horus-pharma.com
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Horus Pharma SAS - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Horus Pharma SAS | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.